Clinical trial
Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.
NCT00154011 · Technische Universität Dresden, Other · Completed
Key facts
| NCT number | NCT00154011 |
|---|---|
| Title | Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone. |
| Official title | Characterization of Vascular Effects of Rosiglitazone. |
| Lead sponsor | Technische Universität Dresden, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | rosiglitazone (drug) |
| Enrollment | 24 |
| Start date | Sep 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: